1. Home
  2. MGX vs ALOT Comparison

MGX vs ALOT Comparison

Compare MGX & ALOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MGX
  • ALOT
  • Stock Information
  • Founded
  • MGX 2018
  • ALOT 1969
  • Country
  • MGX United States
  • ALOT United States
  • Employees
  • MGX N/A
  • ALOT N/A
  • Industry
  • MGX
  • ALOT Computer peripheral equipment
  • Sector
  • MGX
  • ALOT Technology
  • Exchange
  • MGX NYSE
  • ALOT Nasdaq
  • Market Cap
  • MGX 62.1M
  • ALOT 69.2M
  • IPO Year
  • MGX 2024
  • ALOT N/A
  • Fundamental
  • Price
  • MGX $1.45
  • ALOT $9.01
  • Analyst Decision
  • MGX Strong Buy
  • ALOT
  • Analyst Count
  • MGX 4
  • ALOT 0
  • Target Price
  • MGX $13.00
  • ALOT N/A
  • AVG Volume (30 Days)
  • MGX 417.1K
  • ALOT 19.0K
  • Earning Date
  • MGX 08-13-2025
  • ALOT 06-05-2025
  • Dividend Yield
  • MGX N/A
  • ALOT N/A
  • EPS Growth
  • MGX N/A
  • ALOT N/A
  • EPS
  • MGX N/A
  • ALOT N/A
  • Revenue
  • MGX $45,263,000.00
  • ALOT $156,030,000.00
  • Revenue This Year
  • MGX N/A
  • ALOT N/A
  • Revenue Next Year
  • MGX $11.75
  • ALOT N/A
  • P/E Ratio
  • MGX N/A
  • ALOT N/A
  • Revenue Growth
  • MGX N/A
  • ALOT 7.14
  • 52 Week Low
  • MGX $1.23
  • ALOT $7.53
  • 52 Week High
  • MGX $5.50
  • ALOT $17.24
  • Technical
  • Relative Strength Index (RSI)
  • MGX 40.18
  • ALOT 48.12
  • Support Level
  • MGX $1.41
  • ALOT $8.91
  • Resistance Level
  • MGX $1.59
  • ALOT $9.39
  • Average True Range (ATR)
  • MGX 0.13
  • ALOT 0.40
  • MACD
  • MGX -0.02
  • ALOT -0.02
  • Stochastic Oscillator
  • MGX 11.32
  • ALOT 9.17

About MGX METAGENOMI INC

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. The genome editing toolbox includes systems for making small edits such as programmable nucleases, base editors, small RNA-mediated integration systems (RIGS), as well as large gene integration systems including large template RIGS and CRISPR-associated transposases (CASTs). The company is focused on its vivo gene editing for its wholly-owned pipeline while pursuing technology out licensing for ex vivo cell therapy. Its pipeline includes product candidates aimed at addressing disorders like Hemophilia A (through MGX-001), Refractory Hypertension, Cardiovascular diseases, and Wilson's disease, among others.

About ALOT AstroNova Inc.

AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Test & Measurement (T&M). It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.

Share on Social Networks: